Physiological characterization of a novel PPAR pan agonist, 2-(4-(5,6-methylenedioxybenzo[d]thiazol-2-yl)-2-methylphenoxy)-2-methylpropanoic acid (MHY2013)

Recently, agonists targeting multiple peroxisome proliferator-activated receptors (PPARs) have been developed to improve metabolic disorders and minimize the side effects of selective PPAR agonists such as weight gain and dyslipidemia. We newly synthesized six 2-methyl-2-(o-tolyloxy)propanoic acid d...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Hye Jin, Lee, Bonggi, Kim, Dae Hyun, Lee, Eun Kyeong, Chung, Ki Wung, Park, Min Hi, Jeong, Hyoung Oh, Kim, Sung Min, Moon, Kyoung Mi, Kim, Ye Ra, Kim, Seong Jin, Yun, Hwi Young, Chun, Pusoon, Yu, Byung Pal, Moon, Hyung Ryong, Chung, Hae Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370010/
https://www.ncbi.nlm.nih.gov/pubmed/28129657
http://dx.doi.org/10.18632/oncotarget.14818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370010/
https://www.ncbi.nlm.nih.gov/pubmed/28129657
http://dx.doi.org/10.18632/oncotarget.14818

Ejemplares similares